NTAP
56
-4
PHM
57
2
MTCH
37
-2
PCG
78
-2
LEG
24
-5
MAR
63
-2
FRT
46
3
ALL
48
5
ETN
73
-3
WFC
75
-2
CRM
59
-3
ACN
38
-18
MLM
64
3
MMM
30
-3
SCHW
52
-4
DG
19
-2
XEL
48
-2
AMAT
46
-2
ABT
56
2
ADI
54
-2
NTAP
56
-4
PHM
57
2
MTCH
37
-2
PCG
78
-2
LEG
24
-5
MAR
63
-2
FRT
46
3
ALL
48
5
ETN
73
-3
WFC
75
-2
CRM
59
-3
ACN
38
-18
MLM
64
3
MMM
30
-3
SCHW
52
-4
DG
19
-2
XEL
48
-2
AMAT
46
-2
ABT
56
2
ADI
54
-2
Financhill
Back

Chugai Pharmaceutical 10K Form

Buy
58

CHGCF
Chugai Pharmaceutical

Last Price:
49.80
Seasonality Move:
0.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCF News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCF

CHGCF Financial Statistics

Sales & Book Value

Annual Sales: $7.92B
Cash Flow: $749.99M
Price / Cash Flow: 34.82
Annual Sales: $6.62
Price / Book: 7.73

Profitability

EPS (TTM): 1.56390
Net Income (TTM): $2.57B
Gross Margin: $4.98B
Return on Equity: 21.98%
Return on Assets: 20.1%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for CHGCF is 62.81%.
  • The Selling, General & Administrative Expenses for CHGCF have been equal to 10.13% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCF is 29.29% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCF
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.09
Quick Ratio: 4.02

Price-to-Earnings

Trailing P/E Ratio: 36.29
Forward P/E Ratio: 0

CHGCF Technical Analysis vs Fundamental Analysis

Buy
58
Chugai Pharmaceutical (CHGCF) is a Buy

Is Chugai Pharmaceutical a Buy or a Sell?